Last reviewed · How we verify
PUR118
At a glance
| Generic name | PUR118 |
|---|---|
| Sponsor | Pulmatrix Inc. |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Evaluation of the Effect of PUR118 on Ozone Induced Airway Inflammation in Healthy Normal Volunteers (PHASE1)
- A Safety and Tolerability Study OF PUR118 In Subjects With Cystic Fibrosis (PHASE1)
- Safety, Tolerability, and Pharmacodynamic Effect Study of PUR118 (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- PUR118 CI brief — competitive landscape report
- PUR118 updates RSS · CI watch RSS
- Pulmatrix Inc. portfolio CI